
Organization · Venture Capital
Magnificent Ventures
Magnificent Ventures is an impact-oriented venture capital firm that invests in transformative technologies aimed at enhancing human health, longevity, and environmental sustainability. The organization is committed to donating 80% of its profits to social initiatives.
Overview
What Magnificent Ventures does
What Magnificent Ventures is
Magnificent Ventures is an impact-oriented venture capital firm that invests in transformative technologies aimed at enhancing human health, longevity, and environmental sustainability. The organization is committed to donating 80% of its profits to social initiatives.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Structured capabilities
- Funder
- Last reviewed
- April 23, 2026
Official channels
Find Magnificent Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Magnificent Ventures as a funder
Investment thesis
Magnificent Ventures is an impact-oriented VC investing in transformative technologies targeting human health, longevity, food systems, environmental sustainability, and wellbeing. Notable commitment: 80% of profits donated to social initiatives.
Focus narrative
Magnificent Ventures invests in visionary ideas across a spectrum from seed to pre-IPO stages. The organization targets sectors related to food, environment, and human wellbeing, with a mission to generate and redirect resources toward addressing pressing global challenges.
Value beyond capital
Magnificent Ventures adds value to its portfolio companies by providing strategic guidance, access to a network of industry experts, and support in navigating the complexities of scaling transformative technologies.
Focus and fit
- Stages
- Seed · Pre-IPO
- Regions
- Global
Availability
- Currently deploying
- Not published
Portfolio and track record
- Recorded portfolio count
- 1
Portfolio context
One notable portfolio company is CoRegen, which is developing a cancer treatment using CRISPR gene editing technology. CoRegen aims to empower the immune system to target and eradicate cancer cells without the toxicity associated with traditional therapies. Their pre-clinical studies have shown promising results in eliminating cancer in mice.
Connected ecosystem
Continue from Magnificent Ventures
These links use structured organization type, sector, and regional relationships. They do not imply endorsement or commercial similarity.
Same organization type
Structured sector focus
Common questions
What to know about Magnificent Ventures
Upseed classifies Magnificent Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 23, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.